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Thiamine pyrophosphate (TPP) riboswitches regulate
essential genes in bacteria by changing conformation
uponbinding intracellular TPP. Previous studies using
fragment-basedapproaches identifiedsmallmolecule
‘‘fragments’’ that bind this gene-regulatory mRNA
domain. Crystallographic studies now show that,
despite having micromolar Kds, four different frag-
ments bind the TPP riboswitch site-specifically, occu-
pying the pocket that recognizes the aminopyrimidine
of TPP. Unexpectedly, the unoccupied site that would
recognize the pyrophosphate of TPP rearranges into a
structure distinct from that of the cognate complex.
This idiosyncratic fragment-induced conformation,
also characterized by small-angle X-ray scattering
and chemical probing, represents a possible mecha-
nism for adventitious ligand discrimination by the
riboswitch, and suggests that off-pathway conforma-
tions of RNAs can be targeted for drug development.
Our structures, together with previous screening
studies, demonstrate the feasibilityof fragment-based
drug discovery against RNA targets.
INTRODUCTION
Riboswitches are cis-acting mRNA elements that specifically
bind metabolites and modulate expression of genes involved in
the metabolism of their cognate ligand (Roth and Breaker,
2009). Riboswitches are promising antimicrobial targets
because of their highly specific small molecule recognition, prev-
alence in bacteria, and association with genes essential for path-
ogen survival or virulence. Moreover, retrospective studies on
several antimicrobial agents for which the mechanism of action
was previously unknown have revealed that they target ribos-
witches (Deigan and Ferre´-D’Amare´, 2011).
Fragment-based approaches, in which weakly binding small
molecule ‘‘fragments’’ (Mr < 300 Da) are identified in modestly
sized screens and then elaborated into more potent ligands,Chemistry & Biology 21,have emerged as a promising method for drug discovery (Scott
et al., 2012). Although extensively used against protein targets,
only recently has this approach been applied to RNA, leading
to the discovery of several small molecules that bind the Escher-
ichia coli thiM TPP riboswitch aptamer with Kd between 20 and
700 mM (Cressina et al., 2010). Although even the most tightly
binding fragments did not influence expression of a downstream
reporter gene in an in vitro assay (Cressina et al., 2010), a hetero-
cyclic thiamine precursor has been shown to regulate expres-
sion of an endogenous gene via its TPP riboswitch (Moulin
et al., 2013). Thus, even though substantial further development
is necessary, fragments have the potential to be elaborated into
ligands specific for TPP riboswitches. A critical step is to under-
stand the exact mode by which the fragments bind RNA. Indeed,
there are no reports showing that such weakly binding fragments
can be crystallographically visualized bound to an RNA target.
Further elaboration of the fragments is contingent on direct
structural analysis that pinpoints their interaction with the
riboswitch.
RESULTS AND DISCUSSION
Structures of a TPP Riboswitch in Complex with
Fragments
Riboswitch-TPP co-crystal structures demonstrate that this RNA
forms a three-helix junction; twoof the helical arms are bridged by
the bound TPP (Figures 1A and 1B; Edwards and Ferre´-D’Amare´,
2006; Kulshina et al., 2010; Serganov et al., 2006; Thore et al.,
2006). The aminopyrimidine ring of TPP is recognized by stacking
and base pairing-like interactions with the J3/2 joining region of
the ‘‘pyrimidine sensor helix.’’ The thiazole ring of TPP is in van
derWaals contact with the sugar of G72 and, in some TPP-bound
structures, the nucleobase of G72. The pyrophosphate moiety of
TPP is coordinated by two partially hydrated divalent cations
(Ba2+, Mg2+, or Mn2+ in different crystal structures) and makes
direct, and water- and cation-mediated, contacts with residues
in J4/5 and J5/4 in the ‘‘pyrophosphate sensor helix.’’ The RNA
recognizes TPP as a divalent metal-ion chelate, thereby over-
coming its unfavorable electrostatic character.
To understand how compounds considerably smaller than
TPP can bind the TPP riboswitch specifically, and as a starting
point for elaborating these into more potent ligands, we591–595, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 591
Figure 1. TPP- and Fragment-Bound Ribos-
witch Structures
(A) 3D structure of the TPP riboswitch bound to
TPP (Edwards and Ferre´-D’Amare´, 2006) and
secondary structure of the TPP riboswitch.
(B) Interactions between the TPP riboswitch and
bound cations with TPP. Metal ions and water
molecules are in purple and red, respectively.
(C) Interactions between the TPP riboswitch and
bound cation with fragment 4. A portion of a
composite, simulated annealing-omit 2jFoj - jFcj
Fourier synthesis, contoured around the final
refined fragment 4, G72, and the bound metal ion
at 1.0 SD, is in cyan.
See also Table S1 and Figures S1–S3 and S5.
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Fragments Bind and Remodel the TPP Riboswitchdetermined crystal structures of theE. coli thiM TPP riboswitch in
complex with compounds 1–4, identified by previous fragment-
based discovery experiments (Cressina et al., 2010; Table 1) at
resolutions between 2.65 and 3.1 A˚ (Table S1 available online).
These four fragments selectively bind a TPP riboswitch over an
unrelated lysine riboswitch and are representative of the range
of Kd values and structural diversity of the set of 17 fragments
identified previously (Cressina et al., 2010). In each case, the
RNA adopts a global structure that superimposes closely (root-
mean-square deviation = 0.6–0.8 A˚ for 78 or 79 C10 atom pairs)
on that of its TPP complex (Edwards and Ferre´-D’Amare´,
2006; Serganov et al., 2006). Well-defined jFoj-jFcj electron den-
sity features (peak heights >5 SD) appropriate for each of the
fragments were present in J3/2 of the RNA (Figure S1). Even
hypoxanthine (4), which binds the riboswitch with Kd = 670 mM,
exhibited clear unbiased electron density.
Consistent with their conjugated heterocyclic character, frag-
ments 1–4 all occupy the aminopyrimidine-binding site of the
riboswitch. Fragment 4 is representative (Figure 1C). It stacks
between the nucleobases of G42 and A43 and forms hydrogen
bonds with nucleotides in J3/2 and in P2, reminiscent of the
recognition of the aminopyrimidine moiety of TPP.
Idiosyncratic Rearrangement of an Unoccupied Site
In addition to exhibiting features in the aminopyrimidine-binding
site corresponding to the fragments, our experimental electron
density maps unexpectedly indicate that G72 from the pyro-
phosphate sensor helix has rearranged. Alignment of TPP-
bound E. coli thiM TPP riboswitch structures shows G72 in three
distinct conformations (Figure S3). In our structures of the ribos-
witch bound to 1–4, G72 adopts an unprecedented conforma-
tion, with its nucleobase pointing into the pyrophosphate binding
pocket, where it makes contacts with J4/5 or J5/4 through N1
and N2 (Figure 1C; Figure S1). In addition, in the structures
bound to 2–4, unambiguous anomalous difference electron den-
sity corresponding to one Mn2+ is observed (a Mg2+ is observed
in the complex with 1, and a second cation is observed in the592 Chemistry & Biology 21, 591–595, May 22, 2014 ª2014 Elsevier Ltd All rights reservedcomplex with 3). The metal ion is located
in the same position as one of the
pyrophosphate-bound divalent cations
in the TPP complex. Rather than being
coordinated by the pyrophosphate of
TPP, however, in the complexes with1–4, the cation is coordinated by theWatson-Crick face of the re-
arranged G72.
SAXS and SHAPE Characterization of Fragment-
Induced Riboswitch Folding
Previous small-angle X-ray scattering (SAXS) experiments have
shown that the thiM TPP riboswitch compacts in the presence
of physiological Mg2+ concentrations, but achieves complete
folding only when it has bound TPP (Baird and Ferre´-D’Amare´,
2010). Although the conformation of the riboswitch bound to
1–4 in our co-crystals is very similar to that of the TPP-bound
RNA, it is possible that crystallization selected a subset of mole-
cules that had achieved complete folding. To examine the
average global conformation of the fragment-bound riboswitch,
we performed SAXS experiments using 2 as a representative
ligand. As judged by the radius of gyration (Rg) and the distance
distribution function P(r), binding to this fragment results in a de-
gree of compaction intermediate between those of the free and
TPP-bound riboswitch (Figure 2A and Table S2).
We probed the effect of fragment binding to the RNA at sin-
gle-nucleotide resolution using SHAPE (selective 20-hydroxyl
acylation analyzed by primer extension; Wilkinson et al., 2006;
Figure 3A). The riboswitch bound to 2 exhibits regions that
have folded to approximately the TPP-bound structure, while
other regions are only partially folded. At J3/2 and P3, which
together form the pyrimidine-binding pocket, the SHAPE is
low in the fragment-bound structure, in agreement with the
crystallographic observation that the fragment is bound simi-
larly to the aminopyrimidine of TPP. At J2/4, J4/5, and J5/4,
which together form the pyrophosphate-binding pocket, as
well as in L5, the SHAPE reactivity of the fragment-bound
RNA is intermediate between those of the free and TPP-bound
states.
Importance of G72 for Fragment-Induced Folding
We examined the role of G72 in fragment-induced partial folding
by synthesizing G72A and G72U mutant RNAs, and examining
Table 1. Structure and Kd Values for TPP, Thiamine, and
Fragments 1–4
Compound Structure Kd (mM)
TPP 0.01–0.1
Thiamine 1.5
1 49 ± 4
2 103 ± 6
3 280 ± 30
4 670 ± 50
From (Cressina et al., 2010). See also Table S3.
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Fragments Bind and Remodel the TPP Riboswitchthem free or bound to either 2 or TPP. SAXS shows that whereas
the mutations have little impact on the overall conformations of
TPP-bound or free RNA, the mutants are less compact in the
presence of the fragment (Figures 2B and 2C and Table S2), indi-
cating that the G72 mutations inhibit folding, G72Umore so than
G72A. In SHAPE experiments, the ligand-free mutants also
show little change from the wild-type, whereas the TPP-bound
mutants are slightly less ordered than the native sequence
(Figure 3B; Figure S4). In agreement with the SAXS experiments,
SHAPE experiments on the fragment-bound mutants show that
mutations at G72 (particularly G72U) inhibit the ability of the RNA
to fold in the presence of 2. Throughout the entire RNA, but
particularly in L5 and in the TPP-binding site (J3/2, J5/4), the
SHAPE reactivity of the 2-bound mutant RNAs is closer to that
of the free RNA than to the TPP-bound RNA.
Our SHAPE and SAXS data show that a point mutation at
G72, which does not contact fragments 1–4, destabilizes the
fragment-bound TPP riboswitch. G72 is thus critical for frag-
ment-induced partial folding of the TPP riboswitch, presum-
ably due to its metal-mediated and direct interactions with
the pyrophosphate sensor helix. Nucleotides that form the py-
rophosphate binding pocket have previously been shown to be
critical for gene regulation in vivo, and are strongly conserved
(Kulshina et al., 2010; Ontiveros-Palacios et al., 2008). G72
mutants, especially G72U, are unable to recapitulate these
contacts to stabilize the pyrophosphate-binding site, which im-
pairs the ability of the RNA to fold in the presence of the
fragments.
We investigated further the function of G72 in TPP riboswitch
stabilization through isothermal titration calorimetry (ITC; TableChemistry & Biology 21,S3). The G72U mutant binds 2 with a Kd of 100 mM, essentially
the same as wild-type, suggesting that disruption of fragment-
induced folding in a G72U mutant is not due to weaker fragment
binding. Surprisingly, ITC revealed that the G72U mutant binds
TPP with a Kd of2 mM, approximately two orders of magnitude
weaker than wild-type, even though G72U does not significantly
affect the overall shape and local conformation of the unfolded
free RNA or the folded TPP-bound RNA (SAXS and SHAPE
data, respectively). This may be due to the role G72 plays in
stabilizing the L5-P3 tertiary interactions, which have been
shown to be critical for TPP binding and TPP-induced compac-
tion (Kulshina et al., 2010).
Structure of a Thiamine-Bound TPP Riboswitch
To understand the effect of an intermediate-size ligand on the
stability of the pyrophosphate-binding pocket, we solved the
co-crystal structure of the thiM TPP riboswitch with thiamine
(Figure S5). We observe no direct contacts between thiamine
and the pyrophosphate sensor helix. There is no electron density
indicative of either metal ions or a reoriented G72 in the pyro-
phosphate-binding pocket. Furthermore, several nucleotides in
the pyrophosphate-binding pocket are disordered. Relative to
TPP or 1–4, thiamine is shifted out of the pyrimidine-binding
pocket so that stacking of the aminopyrimidine is suboptimal.
The destabilization of the pyrophosphate-binding pocket and
the position of thiamine is reminiscent of a structure of the
RNAbound to the thiamine antimetabolite pyrithiamine (Edwards
and Ferre´-D’Amare´, 2006; Figure S5).
SIGNIFICANCE
Our crystallographic, SAXS, SHAPE, and ITC analyses sug-
gest that the pyrophosphate-binding site of the TPP ribos-
witch can be stabilized either through contact with a metal
ion-bound pyrophosphate moiety or via contacts with a re-
oriented G72. Thiamine and pyrithiamine cannotmake direct
contacts with the pyrophosphate-binding site, but appear to
be large enough to sterically block G72 reorientation. The
inability of thiamine to stabilize the pyrophosphate helix
may be a mechanism to facilitate discrimination in vivo be-
tween TPP and thiamine by the riboswitch.
Despite its polyanionic nature, RNA has been observed to
bind anions and electronegative groups (Auffinger et al.,
2004). An Rfam (Burge et al., 2013) analysis of 115 TPP ribos-
witches indicates that a purine is 99% conserved at residue
72. In addition to facilitating ligand discrimination, a purine
at this position may aid in recognition of the pyrophosphate
moietyofTPP,possibly throughdirectcontactsvia thenucle-
obase, similar to the interaction between a guanine in the
glmS riboswitch-ribozyme and the phosphate of its cognate
ligand, glucosamine-6-phosphate (Klein et al., 2007).
Our co-crystal structures provide direct structural demon-
stration of site-specific binding of fragments derived from a
screen to a target biological RNA. Observation of specific
binding provides proof of concept for RNA-targeted frag-
ment-based methods, and insight into strategies for struc-
ture-based fragment elaboration against an RNA target.
Our results reveal that the fragments studied here induce
an alternate conformation of the TPP riboswitch, distinct591–595, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 593
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CBA Figure 2. SAXS Analysis of Fragment-
Induced RNA Folding
(A) SAXS analysis of the wild-type TPP riboswitch.
P(r) plots reflect differences in shape and
maximum dimension between the ligand-free,
TPP-bound, and fragment 2-bound states of the
riboswitch. SAXS behavior of the wild-type RNA,
free or bound to TPP, is consistent with findings
from a previous report (Baird and Ferre´-D’Amare´,
2010).
(B) SAXS analysis of the G72A TPP riboswitch.
(C) SAXS analysis of the G72U TPP riboswitch.
See also Table S2.
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Fragments Bind and Remodel the TPP Riboswitchfrom that induced by the cognate ligand. This unexpected
structural rearrangement may be exploited to develop small
molecule chemical tools with a mechanism of action remi-
niscent of the anticancer drug Gleevec, which binds to an
off-pathway conformation of the Abl kinase (Schindler
et al., 2000), or of oligonucleotides that promote misfolding
of a group I intron (Childs et al., 2002).EXPERIMENTAL PROCEDURES
Crystallization
For structures bound to 2, 3, 4, and thiamine, TPP riboswitch RNA transcribed
from plasmid pTB13 (150 mM) was incubated with ligand (1 mM fragment 2,wt + 22
1
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1
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0
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nt sequence
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B
594 Chemistry & Biology 21, 591–595, May 22, 2014 ª2014 Elsevier1 mM fragment 3, 0.75 mM fragment 4, or 1 mM thiamine) in 5 mM Tris-HCl
(pH 8.1), 3 mM MgCl2, 10 mM NaCl, 100 mM KCl, 0.5 mM spermine, and
0%–3% (v/v) DMSO at 37C for 30 min. Co-crystals were grown with
hanging-drop vapor diffusion at 21C prepared by mixing 2 ml of an RNA-frag-
ment complex solution with 1 ml of reservoir solution (2: 30% [w/v] polyethyle-
neglycol 2000 [PEG-2000], 0.35 M NH4Cl, 50 mM succinate-KOH [pH 7.0],
10 mM MnCl2; 3: 30% [w/v] PEG-2000, 0.5 M NH4Cl, 50 mM BisTris-HCl
[pH 6.5], 10 mM MnCl2 ; 4: 30% [w/v] PEG-2000, 0.5 M NH4Cl, 50 mM succi-
nate-KOH [pH 7.0], 10 mM MnCl2; thiamine: 30% [w/v] PEG-2000, 0.35 M
NH4Cl, 50 mM succinate-KOH [pH 7.0], and 10 mM ZnCl2). Prior to data
collection, crystals were transferred to drops containing reservoir solution
supplemented with 1 mM fragment and cryoprotectant (15% [v/v] glycerol,
10%–20% [v/v] ethylene glycol or 10%–20% [w/v] sucrose).
For the structure bound to 1, TPP riboswitch RNA derived from the pIDT-
TPP plasmid (500 mM) was mixed with fragment 1 (2 mM) in 50 mM KOAc80
J5/4
80
J5/4
SHAPE 
reactivity 0.7
0.3
Figure 3. SHAPE Analysis of Fragment-
Induced RNA Folding
(A) SHAPE analyses of the ligand-free, fragment 2-
bound and TPP-bound native sequence ri-
boswitch. Black, yellow, and red in SHAPE profiles
denote low, medium, and high reactivities,
respectively. SHAPE data on the wild-type RNA,
free or bound to TPP, are consistent with findings
from a previous report (Steen et al., 2010).
(B) SHAPE analyses of ligand-free, fragment
2-bound, and TPP-bound G72U mutant ri-
boswitches.
See also Figure S4.
Ltd All rights reserved
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Fragments Bind and Remodel the TPP Riboswitch(pH 6.9), 5 mM MgCl2, and 2% (v/v) DMSO. Co-crystals were grown with
hanging-drop vapor diffusion at 21C prepared by mixing 1.5 ml of an RNA-
fragment complex solution with 0.75 ml of reservoir solution (30% [w/v] polye-
thyleneglycol 4000 [PEG-4000], 0.1 MNaOAc [pH 5.1], and 0.3MNH4Cl). Prior
to data collection, crystals were transferred to a drop containing reservoir
solution supplemented with an additional 5% (w/v) PEG-4000, 50 mM KOAc
(pH 6.9), 5 mM MgCl2, and 2 mM fragment 1. Crystals were mounted in nylon
loops and flash-frozen by plunging into liquid nitrogen.
Diffraction Data Collection, Structure Determination, and
Refinement
Diffraction data were collected either at beamlines 5.0.1 or 5.0.2 of the
Advanced Light Source (ALS; 2, 3, 4, and thiamine) and were collected, in-
dexed, integrated, and scaled with the program HKL2000 (Otwinowski and
Minor, 1997) or at beamline 24-ID-C of the Advanced Photon Source
(APS; 1) and collected with the NE-CAT RAPD pipeline and indexed, inte-
grated, and scaled with HKL2000 (Table S1). The structures were solved by
molecular replacement, in which the E. coli thiM TPP riboswitch (1, Protein
Data Bank [PDB] ID 2GDI; 2, 3, 4, thiamine, PDB ID 2HOJ) lacking TPP, metal
ions, or water molecules was used as a search model in the program PHASER
(McCoy et al., 2007). Rounds of manual rebuilding (Jones et al., 1991),
interspersed with simulated-annealing, positional, and restrained individual
B-factor refinement against a maximum likelihood target (Bru¨nger et al.,
1998), yielded the current crystallographic models (Table S1). Small-molecule
coordinates, parameter files, and topology files were obtained from the
PRODRG server (Schu¨ttelkopf and van Aalten, 2004) for the fragments, and
from the HIC-UP server (Kleywegt and Jones, 1998) for thiamine.
ACCESSION NUMBERS
The PDB coordinates and structure factors for the fragment 1-, 2-, 3-, 4-, and
thiamine-bound structures are 4NYA, 4NYB, 4NYC, 4NYD, and 4NYG,
respectively.
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